Literature DB >> 25672641

Coronary artery disease in patients with HIV infection.

Amish A Patel1, Matthew J Budoff.   

Abstract

HIV-infected patients are known to be at risk for premature coronary artery disease. This emerging paradigm is a rising concern for clinicians. Due to advances in the treatment of HIV, this once fatal infection has been transformed into a chronic illness. Traditional risk factors paired with the long-term use of antiretroviral therapy (ART) and chronic inflammation leads to premature atherosclerosis, particularly progression of atherosclerotic plaque. This population of patients requires early recognition of subclinical atherosclerosis, as well aggressive primary and secondary prevention strategies among the multi-disciplinary team of physicians caring for them. We sought to present a comprehensive review of the available literature related to HIV and atherosclerosis and cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25672641     DOI: 10.1007/s40256-015-0105-8

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  7 in total

1.  Short Communication: Accumulation of Neutral Lipids in Liver and Aorta of Nef-Transgenic Mice.

Authors:  Tatiana Pushkarsky; Evgeny Shilov; Natalya Kruglova; Ronald Naumann; Beda Brichacek; Lucas Jennelle; Dmitri Sviridov; Andrei Kruglov; Sergei A Nedospasov; Michael Bukrinsky
Journal:  AIDS Res Hum Retroviruses       Date:  2016-10-25       Impact factor: 2.205

2.  Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.

Authors:  Ji Li; Hong Lai; Shaoguang Chen; Shenghan Lai
Journal:  Int J STD AIDS       Date:  2018-02-22       Impact factor: 1.359

Review 3.  Coronary Artery Disease in Patients with HIV Infection: An Update.

Authors:  Amish A Patel; Matthew J Budoff
Journal:  Am J Cardiovasc Drugs       Date:  2020-11-13       Impact factor: 3.283

4.  Omega 3 Fatty Acids Supplementation and Oxidative Stress in HIV-Seropositive Patients. A Clinical Trial.

Authors:  Norma Amador-Licona; Teresa A Díaz-Murillo; Genaro Gabriel-Ortiz; Fermín P Pacheco-Moises; Texar A Pereyra-Nobara; Juan M Guízar-Mendoza; Gloria Barbosa-Sabanero; Gustavo Orozco-Aviña; Sandra C Moreno-Martínez; Rafael Luna-Montalbán; Eduardo Vázquez-Valls
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

Review 5.  Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.

Authors:  Daniela Sofia Martins Pinto; Manuel Joaquim Lopes Vaz da Silva
Journal:  Curr Cardiol Rev       Date:  2018-03-14

Review 6.  Gut Microbiota and Environment in Coronary Artery Disease.

Authors:  Andrea Piccioni; Tommaso de Cunzo; Federico Valletta; Marcello Covino; Emanuele Rinninella; Pauline Raoul; Christian Zanza; Maria Cristina Mele; Francesco Franceschi
Journal:  Int J Environ Res Public Health       Date:  2021-04-16       Impact factor: 3.390

7.  Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study.

Authors:  Minyahil Woldu; Omary Minzi; Workineh Shibeshi; Aster Shewaamare; Ephrem Engidawork
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.